Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorPeking University Cancer Hospital & Institute
About this trial
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with lung lesions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-75 years old, male or female;
Heart function is normal;
Normal heart function;
Estimated survival ≥12 weeks;
Disqualifiers
Serious abnormality of liver, kidney and blood;
Pregnant patients;
Pregnant and lactation women;
Trial population
patients with lung lesions
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
FDG-PET
Other interventionAll study participants will undergo 18F-FDG PET/CT scan within 1 week
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Standardized uptake value（SUV）
SUV is a semi-quantitative analysis index to describe the radioactive uptake of lesions, which has certain reference value for differentiating benign and malignant lesions. The uptake of the tracer （68Ga-N188） in lung lesions by measuring SUV on PET/CT.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov